UroGen Pharma (URGN) EBT (2017 - 2026)
UroGen Pharma (URGN) posted quarterly EBT of -$28.3 million for Q1 2026, up 34.76% year-on-year from -$21.0 million in Q1 2025, and down 6.41% on a QoQ basis from -$26.6 million in Q4 2025.
UroGen Pharma (URGN) EBT (2017 - 2026) Analysis & Trends
UroGen Pharma (URGN) has reported EBT for 10 consecutive years, with -$28.3 million the latest figure, recorded in Q1 2026.
- Quarterly EBT rose 34.76% year-over-year to -$28.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$138.3 million (down 2.25% YoY) and the FY2025 annual result came in at -$153.4 million, down 23.68% from the prior year.
- EBT declined to -$28.3 million in Q1 2026 per URGN's latest filing, from -$26.6 million in the prior quarter.
- Over the last five years, EBT for URGN reached as high as -$21.9 million in Q3 2023 and fell as low as -$48.9 million in Q2 2025.
- A 5-year average of -$30.1 million and a median of -$28.2 million in 2022 frame the typical range for EBT.
- Annual changes were most pronounced in 2024 — EBT slumped 57.31% — and 2026, when it soared 34.76%.
- Year by year, EBT stood at -$28.2 million in 2022, then climbed by 21.36% to -$22.2 million in 2023, then plunged by 57.31% to -$34.9 million in 2024, then increased by 23.59% to -$26.6 million in 2025, then declined by 6.41% to -$28.3 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$28.3 million, -$26.6 million, and -$34.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | UroGen Pharma | 2.13 Bn | 1.99 Bn | 46.82 Mn | -28.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.35 Mn |
| Dec 31, 2025 | -26.64 Mn |
| Sep 30, 2025 | -34.40 Mn |
| Jun 30, 2025 | -48.93 Mn |
| Mar 31, 2025 | -43.45 Mn |
| Dec 31, 2024 | -34.86 Mn |
| Sep 30, 2024 | -23.58 Mn |
| Jun 30, 2024 | -33.37 Mn |
| Mar 31, 2024 | -32.23 Mn |
| Dec 31, 2023 | -22.16 Mn |
| Sep 30, 2023 | -21.89 Mn |
| Jun 30, 2023 | -24.08 Mn |
| Mar 31, 2023 | -30.19 Mn |
| Dec 31, 2022 | -28.18 Mn |
| Sep 30, 2022 | -25.12 Mn |
| Jun 30, 2022 | -26.66 Mn |
| Mar 31, 2022 | -28.07 Mn |
| Dec 31, 2021 | -27.32 Mn |
| Sep 30, 2021 | -30.21 Mn |
| Jun 30, 2021 | -25.91 Mn |